Immunosuppressive agents
US6531505B2 · kind B2 · utility
45Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 1999 |
| Grant date | Mar 11, 2003 |
| Priority date | — |
| Expiry date | Sep 10, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An immunosuppressive agent which is very effective for treating autoimmune disease, inflammatory reaction, fibrosis or dysfunction caused by autoimmune disease and related disease thereof with tissue injury or infection, rejection of transplantation, graft versus host disease by bone marrow (hematopoietic stem cell) transplantation, or allergic disease, by selectively inhibiting the activated T cells, is provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.